During the past decade, Mehilainen Toolo conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mehilainen Toolo" are "Cardiovascular Disease" (1 trials) and "Irritable Bowel Syndrome" (1 trials). Many other conditions were trialed in "Mehilainen Toolo" in a lesser frequency.

Most popular intervention types in "Mehilainen Toolo" are "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Probiotic (Active high)" (1 trials), "Probiotic (Active low)" (1 trials) and "bococizumab (PF-04950615)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mehilainen Toolo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mehilainen Toolo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mehilainen Toolo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mehilainen Toolo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".